
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
高征, 刘银伟, 张翠月. 温肾开郁通痹汤治疗心肾阳虚型胸痹心痛[J]. 中国实验方剂学杂志, 2012,18(17):264-267.
GAO Zheng, LIU Yin-wei, ZHANG Cui-yue. Observation of Wenshen Kaiyu Tongbi Tang on Chest Stuffiness and Pain with Heart-kidney Yang Deficiency[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(17): 264-267.
高征, 刘银伟, 张翠月. 温肾开郁通痹汤治疗心肾阳虚型胸痹心痛[J]. 中国实验方剂学杂志, 2012,18(17):264-267. DOI:
GAO Zheng, LIU Yin-wei, ZHANG Cui-yue. Observation of Wenshen Kaiyu Tongbi Tang on Chest Stuffiness and Pain with Heart-kidney Yang Deficiency[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(17): 264-267. DOI:
目的: 探讨温肾开郁通痹汤治疗心肾阳虚型胸痹心痛的临床疗效及安全性。 方法: 采取前瞻性研究法将78例心肾阳虚型患者随机按数字法分为治疗组、对照组。治疗组41例
以自拟温肾开郁通痹汤为主加减治疗;对照组37例
口服活血化瘀中药。4周为l个疗程。观察、研究两组治疗前后的症状、心绞痛疗效、心电图、心功能、总疗效及不良反应等。 结果: 治疗组患者心绞痛的显效率、总有效率分别为68.3%
97.6%
对照组分别为45.9%
75.7%;治疗组患者心电图疗效的显效率、总有效率分别为63.4%
95.1%
对照组分别为37.8%
73.0%(组间比较
均P<0.05);治疗组患者中医证候改善的显效率、总有效率分别为68.3%
97.6%
对照组分别为45.9%
75.7% (组间比较
均P<0.05)。 结论: 以温肾开郁通痹汤治疗心肾阳虚型胸痹心痛疗效显著
安全可靠
优于对照组。
Objective: To observe the clinical effect and the safety of Wenshen Kaiyu Tongbi Tang (WSKYTBT) on chest stuffiness and pain with heart-kidney yang deficiency. Method: Using prospective method
78 patients with chest stuffiness and pain with heart-kidney yang deficiency were divided into two groups randomly. The treatment group of 41 patients was given modified self-designed WSKYTBT
and the control group of 37 patients was given Chinese herbs of Huoxue Huayu. The period of treatment was 4 weeks. Items such as symptoms
angina attack
electrocardiogram
cardiac function
adverse reactions were examined before treatment and after treatment. Result: In the treatment group significant efficiency rate and total efficacy rate of clinical symptom of angina pectoris was 68.3%
97.6%
in the control group they were 45.9%
75.7% (P<0.05). In the treatment group significant efficiency rate and total efficacy rate of ECG were 63.4%
95.1%
while in the control group they were 37.8% and 73.0% (P<0.05). On the aspect of the effect on syndrome
significant efficiency rate and total efficacy rate were 68.3% and 97.6% in the treatment group
whle 45.9% and 75.7% in the control group (P<0.05). Conclusion: WSKYTBT can effectively improve the clinical symptoms of the patients with chest stuffiness and pain with heart-kidney yang deficiency
and it is safe and reliable as well.
0
浏览量
3
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621